BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy January 30, 2024
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024 December 6, 2023
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules November 13, 2023
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules November 9, 2023
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care November 2, 2023
BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio Covering Digital Signal Processing Technology and AI November 1, 2023
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals August 24, 2023
BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations August 23, 2023
